Trials / Unknown
UnknownNCT03134625
Metabolite Biomarkers Related to Acute Rejection in Kidney Transplantation
Identification of Metabolite Biomarkers Related to Acute Rejection of Patients With Kidney Transplantation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The development of acute rejection can only be considered in cases with increasing serum creatinine in patients with kidney transplantation. However, the serum creatinine itself is not specific but also accurate for detection of acute rejection. So The specific biomarker is required for acute rejection of kidney transplant. In this study, the investigators will enroll 200 consecutive kidney transplant patients in Seoul National University Hospital and follow up. Serial collection of urine and serum will be done. Acute rejection specific urine metabolite will be found by LC MS/MS.
Conditions
Timeline
- Start date
- 2016-06-28
- Primary completion
- 2023-07-30
- Completion
- 2023-07-31
- First posted
- 2017-05-01
- Last updated
- 2022-05-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03134625. Inclusion in this directory is not an endorsement.